Minireview: vitamin D receptor: new assignments for an already busy receptor.

With its discovery in 1920, the molecule vitamin D achieved prominence as a nutritionally essential vitamin important for calcium homeostasis, particularly in the intestine and bone. Then in 1932, the elucidation of vitamin D's chemical structure revealed that this vitamin was in fact a steroid. But it was not until the late 1960s that it was appreciated that the steroid vitamin D was a precursor of a new steroid hormone, 1alpha,25(OH)2-vitamin D3 [1alpha,25(OH)2D3], that is produced by the kidney acting as an endocrine gland. The discovery in 1969 of the nuclear vitamin D receptor (VDR) for 1alpha,25(OH)2D3 initiated a two-decade-long proliferation of reports that collectively described the broad sphere of influence of the vitamin D endocrine system that is defined by the presence of the VDR in over 30 tissue/organs of man. The new genomic frontiers defined by the cellular presence of the VDR include the immune system's B and T lymphocytes, hair follicle, muscle, adipose tissue, bone marrow, and cancer cells. Unexpectedly in the mid 1980s, a new world of 1alpha,25(OH)2D3-mediated rapid responses (RR) was discovered. These were responses that occurred too rapidly (minutes to an hour) to be explained as the simple consequence of the nuclear VDR regulating gene transcription. Some RR examples include the rapid intestinal absorption of calcium (transcaltachia), secretion of insulin by pancreatic beta-cells, opening of voltage-gated Ca2+ and Cl- channels in osteoblasts, and the rapid migration of endothelial cells. The question then arose as to whether there was a second receptor, apart from the nuclear VDR, which responded to the presence of 1alpha,25(OH)2D3 to generate RR? After some false starts, it now appears that the classic VDR, long known to reside in the cell nucleus, in some cells is also associated with caveolae present in the plasma membrane. Furthermore, the chemical properties of the conformationally flexible 1alpha,25(OH)2D3 allow it to generate different shaped ligands for the VDR that are selective either for genomic or for RR. This minireview summarizes a proposed conformational ensemble model of the VDR that provides insight into how different ligand shapes of 1alpha,25(OH)2D3 acting through the VDR in different cellular locations can selectively mediate both genomic and RR.

[1]  D. Moras,et al.  The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. , 2000, Molecular cell.

[2]  A. Norman,et al.  Presence of a truncated form of the vitamin D receptor (VDR) in a strain of VDR-knockout mice. , 2005, Endocrinology.

[3]  A. Norman,et al.  Rapid modulation of osteoblast ion channel responses by 1alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Norman,et al.  Studies on calciferol metabolism. VII. The effects of actinomycin D and cycloheximide on the metabolism, tissue and subcellular localization, and action of vitamin D3. , 1973, Archives of biochemistry and biophysics.

[5]  M. Haussler,et al.  Chromosomal Receptor for A Vitamin D Metabolite , 1969 .

[6]  H. Koeffler,et al.  The role of the vitamin D endocrine system in health and disease. , 1989, The New England journal of medicine.

[7]  A. Norman.  CHAPTER 23 – 1α,25(OH)2-Vitamin D3–Mediated Rapid and Genomic Responses Are Dependent upon Critical Structure–Function Relationships for Both the Ligand and Receptor(s) , 2005 .

[8]  S. Sine,et al.  Vitamin D in Solution: Conformations of Vitamin D3, α,25-Dihydroxyvitamin D3, and Dihydrotachysterol3 , 1974, Science.

[9]  J. Liao,et al.  Muscle Cell Migration via Activation of Phosphatidylinositol 3-Kinase , 2002 .

[10]  A. Norman,et al.  Studies on the mode of action of calciferol. Biological activity of 1 alpha, 24R,25-trihydroxyvitamin D3 in the chick. , 1977, Archives of biochemistry and biophysics.

[11]  Mar Alvarez,et al.  The Rapid Effects of 1,25-Dihydroxyvitamin D3 Require the Vitamin D Receptor and Influence 24-Hydroxylase Activity , 2004, Journal of Biological Chemistry.

[12]  Anthony W. Norman,et al.  Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model , 2004, Nature Reviews Drug Discovery.

[13]  A. Norman,et al.  Stimulation by 1α,25(OH)2-Vitamin D3 of Whole Cell Chloride Currents in Osteoblastic ROS 17/2.8 Cells , 1997, The Journal of Biological Chemistry.

[14]  A. Norman,et al.  Unoccupied 1,25-dihydroxyvitamin D3 receptors. Nuclear/cytosol ratio depends on ionic strength. , 1980, The Journal of biological chemistry.

[15]  J. Liao,et al.  1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. , 2002, Circulation research.

[16]  A. Norman.  Actinomycin D and the Response to Vitamin D , 1965, Science.

[17]  R. Bouillon,et al.  Comparison of 6-s-cis- and 6-s-trans-locked analogs of 1alpha,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responses. , 1997, Molecular endocrinology.

[18]  A. Norman,et al.  Identification of a specific binding protein for 1 alpha,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. , 1994, The Journal of biological chemistry.

[19]  D. Rich,et al.  Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles. , 2002, Journal of medicinal chemistry.

[20]  M. Haussler,et al.  Evidence for the biologically active form of cholecalciferol in the intestine. , 1970, The Journal of biological chemistry.

[21]  A. Norman,et al.  A specific binding protein/receptor for 1alpha,25-dihydroxyvitamin D(3) is present in an intestinal caveolae membrane fraction. , 2002, Biochemical and biophysical research communications.

[22]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[23]  B. Katzenellenbogen,et al.  Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors Dissociation from Transcriptional Activity , 2001, Cell.

[24]  A. Norman,et al.  Hypercalcemia inhibits the rapid stimulatory effect on calcium transport in perfused duodena from normal chicks mediated in vitro by 1,25-dihydroxyvitamin D3. , 1986, Endocrinology.

[25]  Dino Moras,et al.  Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Norman,et al.  An Insulinotropic Effect of Vitamin D Analog with Increasing Intracellular Ca2+ Concentration in Pancreatic β-Cells through Nongenomic Signal Transduction1. , 1999, Endocrinology.

[27]  M. Haussler,et al.  The association of a metabolite of vitamin D3 with intestinal mucosa chromatin in vivo. , 1968, The Journal of biological chemistry.

[28]  A. Norman,et al.  Studies on the mode of action of calciferol. VI. Effect of 1,25-dihydroxy-vitamin D3 on RNA synthesis in the intestinal mucosa. , 1973, Biochemical and biophysical research communications.

[29]  A. Norman,et al.  Vitamin D: concerning the relationship between molecular topology and biological function. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Y. Yoshimoto,et al.  Calcium transport in perfused duodena from normal chicks: enhancement within fourteen minutes of exposure to 1,25-dihydroxyvitamin D3. , 1984, Endocrinology.

[31]  H. Nowicki,et al.  1,25-Dihydroxycholecalciferol: Identification of the Proposed Active Form of Vitamin D3 in the Intestine , 1971, Science.

[32]  B. Boyan,et al.  Ribozyme knockdown functionally links a 1,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Norman,et al.  The Vitamin D Receptor Is Present in Caveolae-Enriched Plasma Membranes and Binds 1α,25(OH)2-Vitamin D3 in Vivo and in Vitro , 2004 .

[34]  S. Woodman,et al.  Caveolae: From Cell Biology to Animal Physiology , 2002, Pharmacological Reviews.

[35]  A. Norman,et al.  Evidence that annexin II Is not a putative membrane receptor for 1α,25(OH)2‐vitamin D3 , 2004, Journal of cellular biochemistry.

[36]  L. Orci,et al.  The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). , 1982, Endocrine reviews.